We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Side With Regeneron, Sanofi in Patent Case Over Amgen’s Repatha
Drugmakers Side With Regeneron, Sanofi in Patent Case Over Amgen’s Repatha
Three drugmakers have filed amicus briefs in support of Regeneron and Sanofi’s efforts to reverse a district court ruling that validated Amgen patents on Repatha and barred the companies from selling their cholesterol drug Praluent.